Guidance document : risk assessment of patients with cirrhosis prior to elective non-hepatic surgery
© Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ..
As a result of the increasing incidence of cirrhosis in the UK, more patients with chronic liver disease are being considered for elective non-hepatic surgery. A historical reluctance to offer surgery to such patients stems from general perceptions of poor postoperative outcomes. While this is true for those with decompensated cirrhosis, selected patients with compensated early-stage cirrhosis can have good outcomes after careful risk assessment. Well-recognised risks include those of general anaesthesia, bleeding, infections, impaired wound healing, acute kidney injury and cardiovascular compromise. Intra-abdominal or cardiothoracic surgery are particularly high-risk interventions. Clinical assessment supplemented by blood tests, imaging, liver stiffness measurement, endoscopy and assessment of portal pressure (derived from the hepatic venous pressure gradient) can facilitate risk stratification. Traditional prognostic scoring systems including the Child-Turcotte-Pugh and Model for End-stage Liver Disease are helpful but may overestimate surgical risk. Specific prognostic scores like Mayo Risk Score, VOCAL-Penn and ADOPT-LC can add precision to risk assessment. Measures to mitigate risk include careful management of varices, nutritional optimisation and where possible addressing any ongoing aetiological drivers such as alcohol consumption. The role of portal decompression such as transjugular intrahepatic portosystemic shunting can be considered in selected high-risk patients, but further prospective study of this approach is required. It is of paramount importance that patients are discussed in a multidisciplinary forum, and that patients are carefully counselled about potential risks and benefits.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:14 |
|---|---|
| Enthalten in: |
Frontline gastroenterology - 14(2023), 5 vom: 28., Seite 359-370 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Abbas, Nadir [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
ABDOMINAL SURGERY |
|---|
| Anmerkungen: |
Date Revised 16.08.2023 published: Electronic-eCollection Citation Status PubMed-not-MEDLINE |
|---|
| doi: |
10.1136/flgastro-2023-102381 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM360805183 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM360805183 | ||
| 003 | DE-627 | ||
| 005 | 20231226083810.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2023 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1136/flgastro-2023-102381 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1202.xml |
| 035 | |a (DE-627)NLM360805183 | ||
| 035 | |a (NLM)37581186 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Abbas, Nadir |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Guidance document |b risk assessment of patients with cirrhosis prior to elective non-hepatic surgery |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Revised 16.08.2023 | ||
| 500 | |a published: Electronic-eCollection | ||
| 500 | |a Citation Status PubMed-not-MEDLINE | ||
| 520 | |a © Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. | ||
| 520 | |a As a result of the increasing incidence of cirrhosis in the UK, more patients with chronic liver disease are being considered for elective non-hepatic surgery. A historical reluctance to offer surgery to such patients stems from general perceptions of poor postoperative outcomes. While this is true for those with decompensated cirrhosis, selected patients with compensated early-stage cirrhosis can have good outcomes after careful risk assessment. Well-recognised risks include those of general anaesthesia, bleeding, infections, impaired wound healing, acute kidney injury and cardiovascular compromise. Intra-abdominal or cardiothoracic surgery are particularly high-risk interventions. Clinical assessment supplemented by blood tests, imaging, liver stiffness measurement, endoscopy and assessment of portal pressure (derived from the hepatic venous pressure gradient) can facilitate risk stratification. Traditional prognostic scoring systems including the Child-Turcotte-Pugh and Model for End-stage Liver Disease are helpful but may overestimate surgical risk. Specific prognostic scores like Mayo Risk Score, VOCAL-Penn and ADOPT-LC can add precision to risk assessment. Measures to mitigate risk include careful management of varices, nutritional optimisation and where possible addressing any ongoing aetiological drivers such as alcohol consumption. The role of portal decompression such as transjugular intrahepatic portosystemic shunting can be considered in selected high-risk patients, but further prospective study of this approach is required. It is of paramount importance that patients are discussed in a multidisciplinary forum, and that patients are carefully counselled about potential risks and benefits | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a ABDOMINAL SURGERY | |
| 650 | 4 | |a CIRRHOSIS | |
| 650 | 4 | |a PORTAL HYPERTENSION | |
| 700 | 1 | |a Fallowfield, Jonathan |e verfasserin |4 aut | |
| 700 | 1 | |a Patch, David |e verfasserin |4 aut | |
| 700 | 1 | |a Stanley, Adrian J |e verfasserin |4 aut | |
| 700 | 1 | |a Mookerjee, Raj |e verfasserin |4 aut | |
| 700 | 1 | |a Tsochatzis, Emmanouil |e verfasserin |4 aut | |
| 700 | 1 | |a Leithead, Joanna A |e verfasserin |4 aut | |
| 700 | 1 | |a Hayes, Peter |e verfasserin |4 aut | |
| 700 | 1 | |a Chauhan, Abhishek |e verfasserin |4 aut | |
| 700 | 1 | |a Sharma, Vikram |e verfasserin |4 aut | |
| 700 | 1 | |a Rajoriya, Neil |e verfasserin |4 aut | |
| 700 | 1 | |a Bach, Simon |e verfasserin |4 aut | |
| 700 | 1 | |a Faulkner, Thomas |e verfasserin |4 aut | |
| 700 | 1 | |a Tripathi, Dhiraj |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Frontline gastroenterology |d 2010 |g 14(2023), 5 vom: 28., Seite 359-370 |w (DE-627)NLM21315255X |x 2041-4137 |7 nnns |
| 773 | 1 | 8 | |g volume:14 |g year:2023 |g number:5 |g day:28 |g pages:359-370 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1136/flgastro-2023-102381 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 14 |j 2023 |e 5 |b 28 |h 359-370 | ||